Reply to: ‘‘Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis”-Reference-Cited by-同舟云学术

Reply to: ‘‘Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis”

Published:2020-11 Issue:5 Volume:83 Page:e371
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Stephan Carla,Kurban Mazen,Abbas Ossama

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis;Goldburg;J Am Acad Dermatol,2020

2. Comorbidities or different entities? Phenotype variability associated with PSENEN mutations;Li;Br J Dermatol,2019

3. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa;Ralser;J Clin Invest,2017

4. Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma;Weber;Cutis,1990

5. Hidradenitis suppurativa of the nape: description of an atypical phenotype related to severe early-onset disease in men;Agut-Busquet;J Dermatol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications;European Journal of Medicinal Chemistry;2024-09

2. Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-02

3. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study;Clinical, Cosmetic and Investigational Dermatology;2024-01

4. Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications;European Journal of Medicinal Chemistry;2023-09

5. Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data;Clinical, Cosmetic and Investigational Dermatology;2023-09